The Medical Advisor

Executive Summary Cancer is no longer best understood purely as a genetic disease. By 2026, a growing body of research supports a more integrated model: cancer as a metabolic, immunologic, and microenvironmental disorder . This report presents a unified framework: Cancer is a dysregulated adaptive system driven by metabolic flexibility, immune evasion, and microenvironmental control. Key insights: Tumors rely on three dominant fuels : glucose, glutamine, and lactate Mitochondrial dysfunction is central to cancer progression and stemness The tumor microenvironment (TME) actively suppresses immune response Metabolic therapies may enhance—not replace—standard treatments Combination strategies outperform single-agent approaches. Introduction: A Broader View of Cancer Biology Traditional oncology often focuses on genetic mutations and targeted therapies. While mutations are critical, emerging research shows that cancer is also a disease of metabolic dysfunction and immu...

Linoleic acid is a type of fat, or fatty acid, found in vegetable oils, nuts, seeds and animal products. An essential omega-6 fatty acid, linoleic acid is required by the human body in small amounts. Too much, however, can be detrimental to your health. Consumers of a standard American diet are much more likely to get too much linoleic acid than too little. The majority of Americans might be misled by official health recommendations to eat “healthy” vegetable oils. Even the term “vegetable oil” is misleading because it gives you the impression that you are receiving vegetable micronutrients when these oils are actually highly toxic, industrially-processed seed oils. Seed oils are some of the most dangerous items you could eat. This is even more of an issue today as the high amounts of oxidative stress these oils cause seriously impair your immune system and radically increase your risk of all infections. What Is Linoleic Acid?  Linole...

CAR T-cell therapy (Chimeric Antigen Receptor T-Cell) is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as “living drugs.” This article provides a comprehensive list of CAR-T therapy companies worldwide. Read on to learn more about innovative CAR-T cell therapy companies and the technologies they are using to fight cancer. CAR-T Cell Therapy Industry In 1987, Israeli immunologist Dr. Zelig Eshhar from the Weizmann Institute of Science developed the first “chimeric antigen receptor” (CAR), laying the foundation for modern CAR-T cell therapy. CARs are synthetic, engineered receptor proteins designed in the laboratory and do not exist naturally in the human body. Chimeric antigen receptor (CAR) T-cell therapy involves genetically modifying a patient’s own T cells to express these engineered receptors, e...